This opportunity is currently closed.
Sign up for Content Alerts to stay informed when this or related funding opportunities are posted.
New Targets for Diabetes or Obesity-related Metabolic Diseases (European researchers)
The New Targets for Diabetes or Obesity-related Metabolic Diseases Grants are funded by the European Foundation for the Study of Diabetes (EFSD) with an educational grant from MSD (Merck Sharpe & Dohme, the operating name of Merck & Co outside of the USA and Canada). The Grants support European researchers working on the identification and molecular understanding of new targets for the treatment of type 2 diabetes or obesity-related metabolic diseases. Applications are invited from diabetes researchers at non-profit research institutions in Europe and Associated Countries. Applicants must be members of EASD. Funds of 100,000 EUR are available for 1 year or longer. Application closing date: December 1, 2022.
Create or log-in to your free account for more functionalities, including a full display of the eligibility criteria such as location and citizenship requirements.